ScienceDex / Researcher record
Bender, Jeffrey R.
- Targetsite Therapeutics Corporation (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Sustained Excellence
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2001 | $961,378 | 3 | #3,463 |
| 2002 | $1,307,139 | 4 | #2,644 |
| 2003 | $1,503,017 | 4 | #2,388 |
| 2004 | $1,123,371 | 3 | #3,856 |
| 2005 | $1,144,971 | 4 | #3,944 |
| 2023 | $245,000 | 1 | #37,005 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20013 records
- FY20024 records
- FY20034 records
- FY20043 records
- FY20054 records
- FY2023 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award records by amount
NIH award records listing Bender, Jeffrey R. as a PI. Multi-PI records show the full award amount for context.
- 1R43HL170910-01R43Contact PIIL-17A mRNA-targeted oligonucleotide therapeutics in Idiopathic Pulmonary Fibrosis (IPF)$245Kaward amount
Award organization
Organizations that administered FY2023 awards listing Bender, Jeffrey R. as a PI.
FY2023 award administered by Targetsite Therapeutics Corporation ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardTargetsite Therapeutics Corporation
- 2001$500K Cumulative Funding
- 2001Entered Top 50% NationallyRanked #3463
- 2001Entered Top 25% NationallyRanked #3463
- 2002$1M Cumulative Funding
- 2002$2M Cumulative Funding
- 2005$5M Cumulative Funding